Logo image of FATH

FATHOM DIGITAL MANUFACTURING (FATH) Stock Fundamental Analysis

USA - NYSE:FATH - US31189Y2028 - Common Stock

5.05 USD
-0.22 (-4.17%)
Last: 5/20/2024, 8:04:01 PM
Fundamental Rating

2

FATH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. FATH has a bad profitability rating. Also its financial health evaluation is rather negative. FATH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FATH has reported negative net income.
FATH had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: FATH reported negative net income in multiple years.
In multiple years FATH reported negative operating cash flow during the last 5 years.
FATH Yearly Net Income VS EBIT VS OCF VS FCFFATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M

1.2 Ratios

FATH has a Return On Assets (4.87%) which is in line with its industry peers.
The Return On Equity of FATH (22.14%) is better than 84.62% of its industry peers.
Industry RankSector Rank
ROA 4.87%
ROE 22.14%
ROIC N/A
ROA(3y)-41.95%
ROA(5y)-26.99%
ROE(3y)-378.05%
ROE(5y)-230.36%
ROIC(3y)N/A
ROIC(5y)N/A
FATH Yearly ROA, ROE, ROICFATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin of FATH (12.23%) is better than 82.31% of its industry peers.
The Gross Margin of FATH (28.70%) is comparable to the rest of the industry.
FATH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 12.23%
GM 28.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.55%
GM growth 5YN/A
FATH Yearly Profit, Operating, Gross MarginsFATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

FATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FATH has been increased compared to 1 year ago.
The debt/assets ratio for FATH is higher compared to a year ago.
FATH Yearly Shares OutstandingFATH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
FATH Yearly Total Debt VS Total AssetsFATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -2.43, we must say that FATH is in the distress zone and has some risk of bankruptcy.
FATH has a worse Altman-Z score (-2.43) than 85.38% of its industry peers.
FATH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, FATH belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.43
ROIC/WACCN/A
WACC8.6%
FATH Yearly LT Debt VS Equity VS FCFFATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

FATH has a Current Ratio of 0.22. This is a bad value and indicates that FATH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.22, FATH is not doing good in the industry: 97.69% of the companies in the same industry are doing better.
A Quick Ratio of 0.16 indicates that FATH may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.16, FATH is doing worse than 96.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.16
FATH Yearly Current Assets VS Current LiabilitesFATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.40% over the past year.
FATH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.50%.
The Revenue has been growing by 28.90% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)101.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.25%
Revenue 1Y (TTM)-18.5%
Revenue growth 3Y28.9%
Revenue growth 5YN/A
Sales Q2Q%-16.6%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
FATH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.36% yearly.
EPS Next Y-71.29%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.3%
Revenue Next 2Y12.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FATH Yearly Revenue VS EstimatesFATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
FATH Yearly EPS VS EstimatesFATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -2 -4 -6 -8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FATH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FATH Price Earnings VS Forward Price EarningsFATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FATH indicates a slightly more expensive valuation: FATH is more expensive than 71.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.92
FATH Per share dataFATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

FATH's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FATH!.
Industry RankSector Rank
Dividend Yield N/A

FATHOM DIGITAL MANUFACTURING

NYSE:FATH (5/20/2024, 8:04:01 PM)

5.05

-0.22 (-4.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2024-05-15/amc
Earnings (Next)08-12 2024-08-12/bmo
Inst Owners0.09%
Inst Owner Change0%
Ins Owners70.19%
Ins Owner Change0%
Market Cap34.69M
Analysts45.71
Price Target4.85 (-3.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.58%
Min EPS beat(2)-100%
Max EPS beat(2)46.85%
EPS beat(4)3
Avg EPS beat(4)-2.37%
Min EPS beat(4)-100%
Max EPS beat(4)46.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-5.06%
Max Revenue beat(2)-4.2%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)5.13%
Revenue beat(8)2
Avg Revenue beat(8)-2.34%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB N/A
EV/EBITDA 27.92
EPS(TTM)-6.68
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS19.11
BVpS10.56
TBVpS-23.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 22.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 12.23%
GM 28.7%
FCFM N/A
ROA(3y)-41.95%
ROA(5y)-26.99%
ROE(3y)-378.05%
ROE(5y)-230.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.55%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.28
Cap/Depr 19.86%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.16
Altman-Z -2.43
F-Score3
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)42.27%
Cap/Depr(5y)35.26%
Cap/Sales(3y)5.96%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.25%
EPS Next Y-71.29%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.5%
Revenue growth 3Y28.9%
Revenue growth 5YN/A
Sales Q2Q%-16.6%
Revenue Next Year-1.3%
Revenue Next 2Y12.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-153.47%
OCF growth 3YN/A
OCF growth 5YN/A